NextCure, Inc.
NXTC
$0.3612
$0.02647.89%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -11.60M | -11.54M | -15.40M | -17.11M | -14.47M |
| Total Depreciation and Amortization | 674.00K | 700.00K | 701.00K | 790.00K | 824.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 1.38M | 1.33M | 1.42M | 3.33M | 1.81M |
| Change in Net Operating Assets | 2.59M | -1.95M | 3.51M | 385.00K | 1.17M |
| Cash from Operations | -6.97M | -11.45M | -9.78M | -12.61M | -10.67M |
| Capital Expenditure | 34.00K | -170.00K | -301.00K | -37.00K | -13.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 6.92M | 18.48M | 12.46M | 17.92M | 4.18M |
| Cash from Investing | 6.96M | 18.31M | 12.16M | 17.88M | 4.16M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 36.00K | 1.00K | 106.00K | 1.00K | 71.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 36.00K | 1.00K | 106.00K | 1.00K | 71.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 25.00K | 6.85M | 2.49M | 5.28M | -6.44M |